0000919574-15-008758.txt : 20151218 0000919574-15-008758.hdr.sgml : 20151218 20151218170656 ACCESSION NUMBER: 0000919574-15-008758 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151216 FILED AS OF DATE: 20151218 DATE AS OF CHANGE: 20151218 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001293310 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770557236 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 442 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650.243.3100 MAIL ADDRESS: STREET 1: 442 LITTLEFIELD AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moradi David CENTRAL INDEX KEY: 0001658843 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 151297500 MAIL ADDRESS: STREET 1: 379 WEST BROADWAY CITY: NEW YORK STATE: NY ZIP: 10021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Anthion Partners II LLC CENTRAL INDEX KEY: 0001658549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35798 FILM NUMBER: 151297501 BUSINESS ADDRESS: STREET 1: 379 WEST BROADWAY CITY: NEW YORK STATE: NY ZIP: 10012 BUSINESS PHONE: 212-404-6677 MAIL ADDRESS: STREET 1: 379 WEST BROADWAY CITY: NEW YORK STATE: NY ZIP: 10012 4/A 1 p63228343amend.xml OWNERSHIP DOCUMENT X0306 4/A 2015-12-16 2015-12-17 0 0001293310 KALOBIOS PHARMACEUTICALS INC KBIO 0001658549 Anthion Partners II LLC 379 WEST BROADWAY NEW YORK NY 10012 0 0 1 0 0001658843 Moradi David 379 WEST BROADWAY NEW YORK NY 10012 1 0 1 0 Common Stock 2015-12-16 4 P 0 3410 29.32 A 178210 D Common Stock 2015-12-16 4 P 0 3410 29.32 A 178210 I Through Anthion Partners II LLC Common Stock 400000 D On December 16, 2015, in connection with a private placement of the Issuer's securities that was announced and priced on December 3, 2015, Anthion Partners II LLC, on behalf of David Moradi, the Managing Member of Anthion Partners II LLC, acquired 3,410 shares of the Issuer's common stock, par value $0.001 per share, at a purchase price of $29.32 per share (which was the announced price for the private placement). The aggregate purchase price paid by Anthion Partners II LLC, on behalf of David Moradi, in the transaction was $99,981.20. The securities reported herein are owned directly by Anthion Partners II LLC and indirectly by David Moradi, the Managing Member of Anthion Partners II LLC. Both Anthion Partners II LLC and David Moradi are members of a "group" (with other persons) for purposes of Section 13(d) of the Securities Exchange Act of 1934. There is no voting or ownership agreement amongst the group members and the other On December 10, 2015, 200,000 shares were transferred from Anthion Partners II LLC's account to David Moradi's account and are now directly owned by David Moradi. On December 16, 2015, 200,000 additional shares were transferred from Anthion Partners II LLC's account to David Moradi's account and are now directly owned by David Moradi. This Form 4 is being amended to accurately reflect David Moradi's direct ownership and indirect ownership, through Anthion Partners II LLC, in the securities reported herein. Anthion Partners II LLC, By: /s/ David Moradi, Managing Member 2015-12-18 By: /s/ David Moradi 2015-12-18